Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more
Sunzen Biotech Bhd (0148) - Net Assets
Latest net assets as of March 2024: RM140.31 Million MYR
Based on the latest financial reports, Sunzen Biotech Bhd (0148) has net assets worth RM140.31 Million MYR as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM159.04 Million) and total liabilities (RM18.73 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM140.31 Million |
| % of Total Assets | 88.22% |
| Annual Growth Rate | 6.37% |
| 5-Year Change | 64.0% |
| 10-Year Change | N/A |
| Growth Volatility | 15.43 |
Sunzen Biotech Bhd - Net Assets Trend (2016–2023)
This chart illustrates how Sunzen Biotech Bhd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sunzen Biotech Bhd (2016–2023)
The table below shows the annual net assets of Sunzen Biotech Bhd from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | RM149.84 Million | +22.94% |
| 2022-12-31 | RM121.88 Million | +3.20% |
| 2021-12-31 | RM118.10 Million | +35.01% |
| 2020-12-31 | RM87.47 Million | -4.26% |
| 2019-12-31 | RM91.37 Million | -14.56% |
| 2018-12-31 | RM106.94 Million | +7.53% |
| 2017-12-31 | RM99.45 Million | +2.28% |
| 2016-12-31 | RM97.23 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sunzen Biotech Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 60.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM9.33 Million | 6.68% |
| Other Components | RM130.26 Million | 93.32% |
| Total Equity | RM139.59 Million | 100.00% |
Sunzen Biotech Bhd Competitors by Market Cap
The table below lists competitors of Sunzen Biotech Bhd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Trust Stamp Inc
NASDAQ:IDAI
|
$13.06 Million |
|
Kaanapali Land LLC
PINK:KANP
|
$13.06 Million |
|
355690
KQ:355690
|
$13.08 Million |
|
I Yuan Precision Ind Co Ltd
TWO:2235
|
$13.08 Million |
|
Global Blockchain Acquisition Corp. Common Stock
NASDAQ:GBBK
|
$13.05 Million |
|
Jian Sin Industrial Co Ltd
TWO:4502
|
$13.05 Million |
|
LEXINGTO GOLD NEW DL-003
F:XX40
|
$13.05 Million |
|
Everpia Vietnam JSC
VN:EVE
|
$13.04 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sunzen Biotech Bhd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 121,881,200 to 139,591,000, a change of 17,709,800 (14.5%).
- Net income of 4,941,669 contributed positively to equity growth.
- Share repurchases of 1,200,207 reduced equity.
- New share issuances of 102,853 increased equity.
- Other factors increased equity by 13,865,485.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM4.94 Million | +3.54% |
| Share Repurchases | RM1.20 Million | -0.86% |
| Share Issuances | RM102.85K | +0.07% |
| Other Changes | RM13.87 Million | +9.93% |
| Total Change | RM- | 14.53% |
Book Value vs Market Value Analysis
This analysis compares Sunzen Biotech Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | RM0.20 | RM0.25 | x |
| 2017-12-31 | RM0.21 | RM0.25 | x |
| 2018-12-31 | RM0.20 | RM0.25 | x |
| 2019-12-31 | RM0.17 | RM0.25 | x |
| 2020-12-31 | RM0.17 | RM0.25 | x |
| 2021-12-31 | RM0.17 | RM0.25 | x |
| 2022-12-31 | RM0.17 | RM0.25 | x |
| 2023-12-31 | RM0.20 | RM0.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sunzen Biotech Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.76%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 1.22x
- Recent ROE (3.54%) is above the historical average (-3.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -0.13% | -0.33% | 0.38x | 1.09x | RM-9.85 Million |
| 2017 | 3.49% | 1.14% | 2.55x | 1.20x | RM-6.47 Million |
| 2018 | -6.49% | -2.34% | 2.01x | 1.38x | RM-17.63 Million |
| 2019 | -17.79% | -6.75% | 1.87x | 1.40x | RM-25.39 Million |
| 2020 | -15.12% | -16.09% | 0.67x | 1.41x | RM-21.98 Million |
| 2021 | 0.58% | 0.75% | 0.61x | 1.26x | RM-11.13 Million |
| 2022 | 3.08% | 3.86% | 0.64x | 1.24x | RM-8.44 Million |
| 2023 | 3.54% | 5.76% | 0.50x | 1.22x | RM-9.02 Million |
Industry Comparison
This section compares Sunzen Biotech Bhd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $64,219,689
- Average return on equity (ROE) among peers: 16.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sunzen Biotech Bhd (0148) | RM140.31 Million | -0.13% | 0.13x | $13.06 Million |
| Three A Resources Bhd (0012) | $69.82 Million | 14.48% | 0.75x | $21.07 Million |
| Bioalpha Holdings Bhd (0179) | $186.67 Million | -0.69% | 0.16x | $3.34 Million |
| Nova Wellness Group Bhd (0201) | $93.94 Million | 15.49% | 0.11x | $3.85 Million |
| SDS Group Bhd (0212) | $38.22 Million | 20.13% | 2.25x | $13.16 Million |
| PTRB (0260) | $36.06 Million | 33.90% | 1.62x | $6.42 Million |
| MYMBN Berhad (0280) | $35.86 Million | 2.72% | 0.27x | $8.98 Million |
| SBH Marine Holdings Berhad (0300) | $77.33 Million | 10.74% | 0.33x | $4.98 Million |
| Sik Cheong Berhad (0316) | $19.96 Million | 30.20% | 0.23x | $1.75 Million |
| OB Holdings Berhad (0327) | $20.10 Million | 23.44% | 0.52x | $3.03 Million |